Furthermore, cathepsin B expression did not differ significantly between the tumors of patients who received neoadjuvant therapy and patients who did not (p = 0.773) or between patients who had tumor-positive lymph nodes and patients who did not (p = 0.213). Here, CTSB is linked to neoplasm.